Global Med Technologies(R), Inc. Announces Prestigious New Client for Donor and Transfusion Software Installation
July 07 2004 - 10:30AM
PR Newswire (US)
Global Med Technologies(R), Inc. Announces Prestigious New Client
for Donor and Transfusion Software Installation Both SafeTrace(R)
and SafeTrace Tx(R) Selected DENVER, July 7 /PRNewswire-FirstCall/
-- Mayo Clinic, one of the most prestigious medical centers in the
world, has purchased SafeTrace(R) and SafeTrace Tx(R)* from Global
Med Technologies, Inc.'s Wyndgate Technologies(R) division to
provide donor and hospital transfusion software at its Rochester,
Minnesota location. Terms were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Dr.
Mick Ruxin, Chairman and CEO of Global Med Technologies, Inc.,
stated, "We, at Global Med, are very excited to be working with
Mayo Clinic. Wyndgate aspires to support Mayo Clinic's purchase
with its quality of people, reputation for service, commitment to
excellence, and high standards for technological superiority in the
industry." Dr. Ruxin added, "We believe this very significant
business agreement with Mayo Clinic underscores our commitment to
quality and safety in helping healthcare facilities of all sizes
and levels of complexity to manage the Vein-to-Vein(R) cycle from
collection to transfusion." About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health medical
information technology company providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Current clients of Wyndgate's
products and services manage more than 3 million units of blood, or
over 22% of the U.S. blood supply, each year. Together, the
SafeTrace Tx advanced transfusion management system and the
SafeTrace donor management system provide Vein-to-Vein tracking
from donor collection to patient transfusion. For more information
about Global Med's products and services, please call 800-WYNDGATE
or visit http://www.globalmedtech.com/, http://www.peoplemed.com/
and http://www.wyndgate.com/. Statements in this press release that
are not strictly historical are "forward-looking" statements within
the meaning of the Safe Harbor provisions of the federal securities
laws. Forward-looking statements involve risks and uncertainties,
including, but not limited to, continued acceptance of the
Company's products and services in the marketplace, regulatory and
competitive factors, new products and technological changes, the
Company's dependence upon third-party suppliers, and other risks
detailed from time to time in the Company's Form 10-K and other
regularly filed reports. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Press, Patti Larson, Senior Director of Marketing
Development, +1-916-404-8492, , or Investors, Tom Marcinek,
President and COO, +1-916-404-8413, , both of Global Med
Technologies, Inc. Web site: http://www.peoplemed.com/ Web site:
http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/
Copyright